Allergy/Imm

sponsor

Your Unread Messages

Hello, Suzanne Dixon
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kiberd BA et al. - Immunosuppression is associated with an increased risk of cancer in kidney transplant recipients compared to the general population. It is less clear whether standardized cancer mortality ratios (SMRs) are also increased. The findings challenge the notion that cancer is a major cause of premature death in all kidney transplant recipients and has implications for design of cancer prevention strategies in kidney transplant recipients.


Today in Nephrology/Urology...keeping you current

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/23/09

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial
American Journal of Kidney Diseases, 11/19/09

The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09

Today in Surgery/Transplantation...keeping you current

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial
American Journal of Kidney Diseases, 11/19/09

The Alphabet Soup of Kidney Transplantation: SCD, DCD, ECD—Fundamentals for the Practicing Nephrologist
Clinical Journal of the American Society of Nephrology, 11/16/09

Antibody-mediated rejection following transplantation from an HLA-identical sibling
Nephrology Dialysis Transplantation, 10/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address